News

Cut Caffeine to Aid Glucose Control in Type 2


 

ST. LOUIS — Convincing your diabetic patients to stop consuming caffeine could significantly reduce their postprandial glucose levels and possibly improve their overall metabolic control, Richard S. Surwit, Ph.D., said at the annual meeting of the American Association of Diabetes Educators.

It has long been known that caffeine increases blood pressure, heart rate, and levels of stress (also known as “counterregulatory”) hormones, which in turn are associated with reduced insulin sensitivity. In two placebo-controlled studies designed to look specifically at the impact of oral caffeine on carbohydrate metabolism in regular coffee drinkers with type 2 diabetes, Dr. Surwit and his associates at Duke University, Durham, N.C., have shown that although caffeine does not appear to affect fasting blood glucose levels, it has a major impact on both 2-hour postprandial glucose values and insulin levels. The lead author of both studies was James D. Lane, Ph.D., professor of medical psychology at Duke.

Indeed, the magnitude of the effect is in the range of glucose-lowering medications that are taken before meals, such as nateglinide and acarbose, said Dr. Surwit, professor and chief of the division of medical psychology, and vice chairman of the department of psychiatry and behavioral sciences at Duke.

“If you get your patients off caffeine, you can have a 20% improvement in postprandial glucose, for free. … You can't get that effect without spending a few dollars a day for a pill. Here, you're getting it without adding anything to their regimen, just taking something away,” he remarked.

In the first study, 14 habitual coffee drinkers with type 2 diabetes were given gelatin capsules of either 125 mg of anhydrous caffeine plus dextrose filler or the filler alone on 2 days within a 2-week period. After fasting blood was drawn, they ingested 250 mg of caffeine or placebo in two capsules with water, and another fasting blood sample was taken an hour later. The patients then consumed a liquid meal containing 75 g of carbohydrates (Boost), and additional blood samples were taken at 1 and 2 hours after the meal (Diabetes Care 2004;27:2047–8).

Caffeine did not affect the fasting levels of plasma glucose or insulin, compared with placebo. After the liquid meal, however, glucose levels were 21% higher and insulin levels were 48% higher when the patients had consumed caffeine before the meal, compared with when they hadn't.

The second study was designed to overcome the first study's limitation of using caffeine-containing capsules rather than real coffee or tea, both of which contain numerous organic compounds that might independently affect glucose tolerance positively or negatively. This time, another group of 20 patients with type 2 diabetes who were also regular coffee drinkers were given decaffeinated coffee with or without 250 mg of anhydrous caffeine dissolved into it, roughly equivalent to a 16-ounce mug of regular brewed coffee. This method allowed for precise control of caffeine content and equivalence of other chemical compounds present in coffee—such as magnesium and roasted quinides—that might influence blood sugar levels, said Dr. Surwit, who is also co-director of Duke's Behavioral Endocrinology Clinic.

Again, there was a significant postprandial effect: The mean glucose value following caffeine consumption was 28% higher than it was without caffeine, and the mean insulin values were 19% higher than they were without caffeine (Endocr. Pract. 2007;13:239–43).

Getting patients to quit drinking caffeine may be tricky, but it's not impossible. “It doesn't take more than 3 or 4 days to get people completely off caffeine,” he said.

Dr. Surwit is the author of “The Mind-Body Diabetes Revolution,” which teaches patients methods of reducing stress hormone levels to obtain better glucose control. Information is available at www.richardsurwit.com

'If you get your patients off caffeine, you can have a 20% improvement in postprandial glucose, for free.' DR. SURWIT

Recommended Reading

Telmisartan Beats Losartan in Proteinuria Drop
MDedge Endocrinology
Nearly Half of Diabetes Patients Short of Tx Goals
MDedge Endocrinology
Self-Monitoring Falls Short in Type 2 Diabetes
MDedge Endocrinology
Screening for Kidney Disease Vital in Diabetes
MDedge Endocrinology
Patient Selection Key for Monitor/Pump Success
MDedge Endocrinology
Reteaching Insulin Injection Improves Glycemic Control
MDedge Endocrinology
Older Type 2 Drugs as Effective as Newer Ones
MDedge Endocrinology
Metformin Rated a 'Best Buy' For Type 2 Diabetes Patients
MDedge Endocrinology
MODY Seen in 5% of Antibody-Negative Children
MDedge Endocrinology
Inhaled Insulin Appears Safe for Children, Three Studies Show
MDedge Endocrinology